Category «Drugs for Neglected Diseases initiative DNDi»

Fosravuconazole L-lysine ethanolate, ホスラブコナゾール L-リシンエタノール付加物

It’s only fair to share… C23H20F2N5O5PS▪C6H14N2O2▪C2H6O : 739.73 [914361-45-8] [(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl dihydrogen phosphate;(2S)-2,6-diaminohexanoic acid;ethanol L-Lysine [[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl]oxy]methyl dihydrogen phosphate ethanol BFE-1224 BMS-379224 E-1224 ravuconazole prodrugs, ravuconazole methyl phosphate fosravuconazole bis(L-lysine) ホスラブコナゾール L-リシンエタノール付加物 Formula C23H20F2N5O5PS. C6H14N2O2. C2H6O CAS 914361-45-8 Mol weight 739.727 Antifungal, Ergosterol biosynthesis inhibitor Fungal infection; Onychomycosis; Trypanosoma cruzi infection PMDA JAPAN APPROVED 2018/1/19 PMDA APPROVED Fosravuconazole L-lysine ethanolate Nailin …